TOP 20 Animal Health Companies of 2020 by Total Revenue
- Humans depends on livestock for survival and Animal Health has always been an issue to look for since it directly reflects the betterment of human life
- For a country’s economy and balanced human life, proper care and disease-free health of animals play a key role. Since rapid environmental change has targeted animal health, it becomes important to expand the innovation procedure in the field of medicines meant for animal health
- In the Top 20 ledgers, Zoetis ensured the top position with total revenue of $6.67B. Our team at PharmaShots has compiled the report of the top 20 Animal Health companies based on the 2020 animal health revenue
20. ZYDUS ANIMAL HEALTH AND INVESTMENT (ZAHL)
Revenue: $0.08B
Founded: 2000
Market Cap: $6.32B
Total Employees: 24,412
Headquarters: Ahmedabad, India
Stock Exchange: NSE
Zydus Animal Health is an Indian company that works and targets its efforts in the business of production, marketing, and distribution of animal health and veterinary products. In 2021, ZAHL entered into a business transfer agreement to sell and transfer its animal healthcare unit. For the year 2020, ZAHL recorded total sales of $0.08B.
19. KRKA
Revenue: $0.09B
Founded: 1954
Market Cap: $4.0B
Total Employees: 11, 677
Headquarter: Novo Mesto-Slovenia, Europe
Stock Exchange: WSE
KRKA is a multinational pharmaceutical company that focuses its key targets on the production and sale of prescription pharmaceuticals, non-prescription products, and animal health products. It supplies a broad range of products for companion animals with new combinations, pharmaceutical forms, and technologies. KRKA is the second pharmaceutical company in terms of manufacturing animal health products in the market. In 2020, KRKA recorded total sales of $0.09B in the animal health market.
18. ANIMALCARE
Revenue: $0.09B
Founded: 1988
Market Cap: $0.27B
Total employees: 200
Headquarter: North Yorkshire, England
Stock Exchange: LON
AnimalCare is a multinational group that focuses on developing and bringing new and innovative animal health products. It exports its products in around 40 countries in Europe and worldwide. Animalcare is expecting to launch Daxocox in 2021. In September 2020, AnimalCare signed an agreement with Kane Biotech to create a joint venture called STEM Animal Health. In 2020, AnimalCare recorded sales of $0.09B from the animal health sector.
17. ORION
Revenue: $0.10B
Founded: 1917
Market Cap: $0.11B
Total Employees: 3,311
Headquarter: Espoo, Finland
Stock Exchange: NYSE
Orion is a globally leading pharmaceutical company that develops and manufactures proprietary, specialty, and animal health products. In June 2020, USFDA granted authorization to Clevor. In 2020, Orion generated total revenue of $0.10B from its animal health segment.
16. OURO FINO SAUDE ANIMAL
Revenue: $0.14B
Founded: 1987
Market Cap: $0.24B
Total Employees: 1212
Headquarter: Paulo, Brazil
Stock Exchange: BVMF
Ouro Fino Saude Animal operates as a pharmaceutical company that focuses on the manufacturing and marketing of veterinary and animal healthcare products. The company is involved in the research and development of veterinary drugs and vaccines. In 2020, Ouro Fino Saude Animal recorded sales of $0.14B.
15. ECO ANIMAL HEALTH
Revenue: $0.14B
Founded: 1972
Market Cap: $0.14B
Total Employees: 204
Headquarter: New Malden, England
Stock Exchange: LON
Eco Animal health is a global leader specializing in high-quality medicines for the animal health sector. In June 2020, Eco animal health received European marketing authorization for the use of Aivlosin for the treatment and metaphylaxis of Mycoplasma hyopneumoniae in pigs. In 2020, Eco animal health generated total revenue of $0.14B.
14. SEQUENT SCIENTIFIC LIMITED
Revenue: $0.18B
Founded: 2002
Market Cap: $0.52B
Total Employees: 1,952
Headquarter: Bangalore, India
Stock Exchange: NSE
Sequent Scientific Limited is one of India’s largest animal health companies that has expanded its business in over 100 countries. It is among the Top 20 animal health companies. In December 2020, Sequent launched Citramox in 10 European countries. In 2020, Sequent Scientific Limited recorded sales of $0.18B.
13. HESKA
Revenue: $0.19B
Founded: 1988
Market Cap: $1.83B
Total Employees: 347
Headquarter: Loveland-Colorado-United States
Stock Exchange: NASDAQ
Heska is a US-based rapidly emerging pharmaceutical company providing the benefits of the latest generation technologies for animal health care. It focuses on selling veterinary and animal health products. In April 2020, Heska completed the acquisition of Scil animal care company. In October 2020, it also completed acquisition of Optomed. In 2020, Heska recorded total sales of $0.19B.
12. NEOGEN
Revenue: $0.41B
Founded: 1982
Market Cap: $4.83B
Total Employees: 1,800
Headquarter: Lansing-Michigan, United States
Stock Exchange: NASDAQ
Neogen develops and markets products and services dedicated to food and animal safety. The company's diagnostic products are used by food and animal producers to test for foodborne bacteria, food allergens, natural toxins, drugs, chemical residues, plant diseases, and quality assurance. In March 2020, Neogen completed the acquisition of Chilean food and animal safety company. In 2020, Neogen recorded total sales of $0.41B.
11. VETOQUINOL
Revenue: $0.52B
Founded: 1933
Market Cap: $1.77B
Total Employees: 2,200
Headquarter: Lure, France
Stock Exchange: EPA
Vetoquinol is a France based one of the largest veterinary pharmaceutical companies in the world. In September 2020, Vetoquinol completed the acquisition of Profender and Drontal product families. Vetoquinol is growing and expanding its animal health market with countries like brazil. In 2020, Vetoquinol Generated total revenue of $0.52B.
10. KYORITSU SEIYAKU
Revenue: $0.54B
Founded: 1955
Market Cap: N/A
Total Employees: 1,375
Headquarter: Chiyoda-ku, Tokyo
Stock Exchange: N/A
Kyoritsu Seiyaku is a Japan-based pharmaceutical company that targets its efforts for manufacturing drugs for animals. It offers a wide range of animal health products at comprehensively reduced costs. In 2020. Kyoritsu Seiyaku recorded total revenue of $0.54B.
9. PHIBRO ANIMAL HEALTH
Revenue: $0.833B
Founded: 1946
Market Cap: $0.85B
Total Employees: 1,725
Headquarter: New Jersey, United States
Stock Exchange: NASDAQ
Phibro Animal Health is a leading global developer and diversified nutrition and animal health company. The company derives its total revenue from the segment-animal health and nutrition. In 2020, Phibro animal health recorded total sales of $0.83B from its animal health segment.
8. DECHRA PHARMACEUTICALS
Revenue: $0.839
Founded: 1997
Market Cap: $7.21B
Total Employees: 1,889
Headquarter: Lostock Gralam, United Kingdom
Stock Exchange: LON
Dechra Pharmaceuticals is a globally specializing company focused on developing, manufacturing, and marketing sales of high-quality products for the veterinary market worldwide. The company works for the global improvement of animal health. In 2020, Dechra Pharmaceuticals recorded total sales of $0.71B from its animal health segment.
7. VIRBAC
Revenue: $1.14B
Founded: 1968
Market Cap: $4.03B
Total Employees: 4,900
Headquarter: Carros, France
Stock Exchange: EPA
Virbac is a French company that is dedicated to animal healthcare. Virbac is helping to advance the field of animal care by innovating the best quality products. In 2020, Virbac generated total revenue of $1.14B.
6. IDEXX LABORATORIES
Revenue: $2.38B
Founded: 1983
Market Cap: $52.92B
Total Employees: 9,300
Headquarter: Westbrook, Maine, United States
Stock Exchange: NASDAQ
Idexx Laboratories is an American multinational corporation that provides diagnostic, detection, and information systems for veterinary, food, and water testing applications. In 2020, Idexx generated total revenue of $2.38B in the animal health segment.
5. ELANCO
Revenue: $3.27B
Founded: 1954
Market Cap: $13.41B
Total Employees: 10,200
Headquarter: Greenfield, Indiana, United States
Stock Exchange: NYSE
ELANCO is a US-based health care company that innovates, develops, and manufactures products for animals. In August 2020, Elanco completed the acquisition of Bayer animal health. In October 2020, Elanco’ Elura received US FDA approval. In 2020, Elanco recorded higher sales of $3.27B in comparison to that in 2019.
4. COVETRUS
Revenue: $4.33B
Founded: 2018
Market Cap: $2.70B
Total Employees: 5,657
Headquarter: Portland, Maine
Stock Exchange: NASDAQ
Covetrus is a growing animal health care company that provides medicines for the treatment and safety of animals. It is the world’s largest supply chain provider of animal health care products. In 2020, Covetrus recorded higher sales in comparison to that in 2019. In 2020, Covetrus generated total revenue of $4.33B.
3. MERCK
Revenue: $4.70B
Founded: 1891
Market Cap: $192.38B
Total Employees: 74,000
Headquarter: Kenilworth, New Jersey, United States
Stock Exchange: NYSE
MSD Animal Health, a division of Merck & Co provides innovative portfolios along with services and technologies to prevent, treat and control diseases across all major farm and companion animal species. In July 2020, Merck Animal Health received FDA approval for Bravecto. In August 2020, Merck animal health completed the acquisition of IdentiGen. In 2020, Merck Animal Health recorded total revenue of $4.70B.
2. BOEHRINGER INGELHEIM
Revenue: $5.03B
Founded: 1885
Market Cap: N/A
Total Employees: 51,944
Headquarter: Ingelheim am Rhein, Germany
Stock Exchange: N/A
Boehringer Ingelheim is a globally leading and research-driven biopharmaceutical company. It is one of the largest providers of veterinary vaccines and medicines. In the Animal health category, the company’s key drug Nexgard generated sales of $0.98B. In 2020, Boehringer Ingelheim generated total revenue of $5.03B from its animal health segment.
1. ZOETIS
Revenue: $6.67B
Founded: 2012
Market Cap: $114.29B
Total Employees: 11,300
Headquarter: Madison, New Jersey, United States
Stock Exchange: NYSE
Zoetis is a rapidly growing leader in the animal health care industry focusing its targets on advancing the health of animals. It focuses on developing a diverse portfolio of animal health products. In February 2020, Zoetis received FDA approval for Simparica Trio, a new combination parasite preventative for Dogs. In November 2020, Zoetis Received European Commission Marketing Authorization for Librela. In 2020, Zoetis recorded total sales of $6.67B.
Related Post: Top 20 Animal Health Companies Based on 2019 Revenue
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com